Electronic Equipment, Instruments and Components
Company Overview of MC10, Inc.
MC10, Inc. engages in developing electronic systems through its conformal electronics platform. Its platform enhances and enables new applications by allowing high performance electronics to occupy spaces and geometries. The company’s technology uses high performance semiconductors in conjunction with interconnect and packaging technologies to produce conformal electronics. It offers its solutions for applications in consumer electronics, medical devices, industrial products, defense systems, differentiated consumer products, industrial, and military markets. The company was founded in 2008 and is based in Cambridge, Massachusetts.
36 Cameron Avenue
Cambridge, MA 02140
Founded in 2008
Key Executives for MC10, Inc.
Chief Executive Officer and President
Co-Founder and Vice President of Business Development
Co-Founder and Technical Advisor
Compensation as of Fiscal Year 2014.
MC10, Inc. Key Developments
MC10, Inc. Hires Scott Pomerantz as its New Chief Executive Officer and President
Sep 16 14
MC10, Inc. announced that it has hired former Broadcom executive, Scott Pomerantz as its new Chief Executive Officer and President. Pomerantz joins MC10 from a 7-year career with Broadcom, where he most recently served as the Senior Vice President and General Manager of Wireless Connectivity, Broadcom's large business. Prior to Broadcom, he co-founded Global Locate, where he served as CEO, President and Chairman of the Board before it was sold to Broadcom in 2007. With his extensive leadership experience and wireless communications knowledge, Pomerantz will lead the company in its development of innovative wearable and stretchable electronics products and platforms.
MC10 Inc. and UCB Partner for Innovative Solutions for Patients with Neurological Disorders
Jul 28 14
MC10 Inc. and UCB announced that they have entered into a partnership to develop MC10's Biostamp platform for patient-focused disease management solutions. The collaboration will evaluate the integration of MC10's novel, conformal sensing platform with UCB's pharmaceutical products to make a positive difference in the lives of people living with severe neurological disorders. MC10 develops stretchable, electronic sensing systems that bend, flex, and twist to match the properties of the human body. MC10's Biostamp platform offers a unique, patient-friendly solution for disease monitoring and management. This passive monitoring of patient health data will not only help patients but also doctors to provide more personalized care. Additionally, it could help to accelerate neuroscience clinical research and provide insight into the real world impact of therapies.
MC10, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 02:10 PM
Mar 14 14
MC10, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 02:10 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Nirav Sheth.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 13, 2013